Suppr超能文献

双嘧达莫与腺苷作为药理学冠状动脉血管扩张剂在利用铊 201 显像检测冠状动脉疾病中的比较。

Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging.

作者信息

Taillefer R, Amyot R, Turpin S, Lambert R, Pilon C, Jarry M

机构信息

Department of Nuclear Medicine, Hötel-Dieu de Montréal, Université de Montréal, Canada.

出版信息

J Nucl Cardiol. 1996 May-Jun;3(3):204-11. doi: 10.1016/s1071-3581(96)90034-3.

Abstract

BACKGROUND

Both dipyridamole and adenosine are widely used as pharmacologic stressors with 201Tl imaging for detection of coronary artery disease. The purpose of this study was to compare dipyridamole and adenosine 201Tl imaging directly in patients with angiographically proved coronary artery disease.

METHODS AND RESULTS

Fifty-four patients were submitted to two planar 201Tl studies: one with dipyridamole and the other with adenosine. The interval between the two studies varied from 2 to 7 days and the order was assigned randomly. Three standard planar views were obtained 10 minutes and 4 hours after the injection of 3.0 mCi 201Tl. Administration of dipyridamole was as follows: 0.142 mg/kg/min during 4 minutes, followed by a slight exercise and 201Tl injection. The infusion of adenosine was as follows: 0.140 mg/kg/min during 6 minutes with injection of 201Tl after the third minute of infusion. Patients were asked to give their preference considering the number, type, severity, and duration of side effects on a scale from 0 (worst) to 5 (best). Reading was done by two experienced observers. The heart was divided into three segments per view. The change in systolic blood pressure was -12 +/- 11 mm Hg for adenosine and -5 +/- 10 mm Hg for dipyridamole (p < 0.001), and the change in heart rate was 18 +/- 10 beats/min for adenosine and 8 +/- 7 beats/min for dipyridamole (p < 0.001). With regions of interest, ischemic/normal wall ratios were determined: 0.78 +/- 0.06 for adenosine and 0.83 +/- 0.08 for dipyridamole (p < 0.001). Adenosine detected 295 normal, 170 ischemic, and 21 scar segments, whereas dipyridamole detected 326, 135, and 25 segments, respectively. Patients preferred adenosine (4.3 +/- 1.0 for adenosine vs 3.8 +/- 1.5 for dipyridamole; p < 0.04) mainly because of the short duration of side effects.

CONCLUSION

This study shows that the use of adenosine with 201Tl imaging may have some advantages over dipyridamole.

摘要

背景

双嘧达莫和腺苷均被广泛用作药物负荷剂,与铊-201心肌显像一起用于检测冠状动脉疾病。本研究的目的是直接比较双嘧达莫和腺苷铊-201心肌显像在经血管造影证实患有冠状动脉疾病的患者中的情况。

方法与结果

54例患者接受了两项平面铊-201心肌显像研究:一项使用双嘧达莫,另一项使用腺苷。两项研究之间的间隔时间为2至7天,顺序随机分配。在注射3.0毫居里铊-201后10分钟和4小时获取三个标准平面视图。双嘧达莫的给药方式如下:在4分钟内以0.142毫克/千克/分钟的速度给药,随后进行轻微运动并注射铊-201。腺苷的输注方式如下:在6分钟内以0.140毫克/千克/分钟的速度输注,在输注第三分钟后注射铊-201。要求患者根据副作用的数量、类型、严重程度和持续时间,以0(最差)至5(最佳)的量表给出他们的偏好。由两名经验丰富的观察者进行解读。每个视图将心脏分为三个节段。腺苷组收缩压变化为-12±11毫米汞柱,双嘧达莫组为-5±10毫米汞柱(p<0.001),腺苷组心率变化为18±10次/分钟,双嘧达莫组为8±7次/分钟(p<0.001)。通过感兴趣区确定缺血/正常心肌壁比值:腺苷组为0.78±0.06,双嘧达莫组为0.83±0.08(p<0.001)。腺苷检测出295个正常节段、170个缺血节段和21个瘢痕节段,而双嘧达莫分别检测出326个、135个和25个节段。患者更喜欢腺苷(腺苷为4.3±1.0,双嘧达莫为3.8±1.5;p<0.04),主要是因为副作用持续时间短。

结论

本研究表明,腺苷与铊-201心肌显像联合使用可能比双嘧达莫具有一些优势。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验